Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications

Rafe Hunter Hall, Carson L. Wright, Griffin K. Hughes, Andriana M. Peña, Chase Ladd, Brooke Gardner, Ryan McIntire, Matt Ferrell, Jane Rubenstein, Jordan Tuia, Alyson Haslam, Vinay Prasad, Matt Vassar

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science